Uninterrupted Novel Oral Anticoagulants and Warfarin Use for Peri-procedural Anticoagulation during Atrial Fibrillation Ablation

被引：0
|
作者：
Kanmanthareddy, Arun K. [1 ]
Buddam, Avanija R. [2 ]
Reddy, Madhu [3 ]
Alla, Venkata M. [1 ]
Hunter, Claire [4 ]
Lakkireddy, Dhanunjaya [3 ]
机构：
[1] Creighton Univ, Sch Med, Omaha, NE USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[3] Univ Kansas Hosp, Kansas City, KS USA
[4] Creighton Univ, Cardiac Ctr, Omaha, NE 68178 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 15期
关键词：
Ablation; radiofrequency; Anticoagulants; oral; Atrial fibrillation;
D O I：
10.1016/j.jacc.2015.08.230
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-215
引用
收藏
页码：B82 / B83
页数：2
相关论文
共 50 条
  • [1] Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
    Winkle, Roger A.
    Mead, R. Hardwin
    Engel, Gregory
    Kong, Melissa H.
    Patrawala, Rob A.
    EUROPACE, 2014, 16 (10): : 1443 - 1449
  • [2] Safety and efficacy of uninterrupted treatment with edoxaban or warfarin during the peri-procedural period of catheter ablation for atrial fibrillation
    Naito, Kazuya
    Nakano, Masataka
    Iwasa, Atsushi
    Maeno, Yoshio
    Shintani, Yoshiaki
    Yamakawa, Takeshi
    Miyashita, Kotaro
    Oyama, Keishiro
    Nakai, Daisuke
    Katagiri, Masaya
    Kido, Hideaki
    Masuda, Shinichiro
    Kohashi, Keiichi
    Kawamata, Tetsuya
    Tanimoto, Shuzou
    Masuda, Naoki
    Ogata, Nobuhiko
    Isshiki, Takaaki
    JOURNAL OF ARRHYTHMIA, 2020, 36 (04) : 634 - 641
  • [3] Peri-procedural novel oral anticoagulants dosing strategy during atrial fibrillation ablation: A meta-analysis
    Mao, Yin-Jun
    Wang, Hang
    Huang, Pin-Fang
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (10): : 1104 - 1114
  • [4] Peri-procedural Anticoagulation in Catheter Ablation Atrial Fibrillation: A Review
    Vrachatis, Dimitrios A.
    Giannopoulos, Georgios
    Kossyvakis, Charalambos
    Panagopoulou, Vasiliki
    Vavuranakis, Manolis
    Papaioannou, Theodore G.
    Pagoni, Stamatina
    Pyrgakis, Vlasios N.
    Cleman, Michael W.
    Deftereos, Spyridon G.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (09) : 1334 - 1345
  • [5] Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
    Vazquez, Sara R.
    Johnson, Stacy A.
    Rondina, Matthew T.
    THROMBOSIS RESEARCH, 2010, 126 (02) : E69 - E77
  • [6] Dabigatran is as Safe as Warfarin for Peri-Procedural Anticoagulation in Atrial Fibrillation Ablation: A Meta-Analysis
    Swaminathan, Paari Dominic
    Prasath, Arun
    Makki, Nader
    Kalamkar, Prachi
    Bhatt, Paras
    Clancy, Jude
    CIRCULATION, 2013, 128 (22)
  • [7] Editorial to "Safety and Efficacy of Uninterrupted Treatment with Edoxaban or Warfarin During the Peri-Procedural Period of Catheter Ablation for Atrial Fibrillation"
    Fukaya, Hidehira
    JOURNAL OF ARRHYTHMIA, 2020, 36 (04) : 642 - 643
  • [8] Safety of Novel Oral Anticoagulants Compared with Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation
    Lindsley, John
    Armbruster, Heather
    Moranville, Michael
    Habibi, Mohammadali
    Khurram, Irfan
    Spragg, David D.
    Berger, Ronald D.
    Calkins, Hugh
    Marine, Joseph E.
    CIRCULATION, 2014, 130
  • [9] Safety of Novel Oral Anticoagulants Compared With Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation
    Armbruster, Heather L.
    Lindsley, John P.
    Moranville, Michael P.
    Habibi, Mohammadali
    Khurram, Irian M.
    Spragg, David D.
    Berger, Ronald D.
    Calkins, Hugh
    Marine, Joseph E.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (03) : 278 - 284
  • [10] Dabigatran versus Warfarin Therapy for Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation
    Maddox, William
    Kay, G. Neal
    Yamada, Takumi
    Osorio, Jose
    Doppalapudi, Harish
    Plumb, Vance J.
    Gunter, Alicia
    Mcelderry, H. Thomas
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2013, 24 (08) : 861 - 865
12345